NCT06395701View on ClinicalTrials.gov

Trimodality Treatment in Bladder Cancer

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

June 2, 2024

Study Completion Date

June 2, 2024

Conditions

Bladder CancerUrinary Bladder NeoplasmsBladder Disease

Interventions

RADIATION

radioteraphy and chemotherapy after RTU --trimodality therapy--

TMT ( trimodality treatment) consists of complete and maximal TURBT of the bladder tumor, followed by definitive radiotherapy combined with a radiosensitizing agent.

Trial Locations (1)

08225

Hospital de Terrassa, Terrassa

All Listed Sponsors

lead

Consorci Sanitari de Terrassa

OTHER

NCT06395701 - Trimodality Treatment in Bladder Cancer | Biotech Hunter | Biotech Hunter